Dipna Pharmachem — 360° view

Dipna Pharmachem, a company in the Pharmaceuticals industry, reported revenue of ₹24 crore and net profit of ₹0.39 crore for the June 2026 quarter.

Dipna Pharmachem (BSE: DPL) closed at ₹3.90 on 20 Nov 2026, down 74.8% over the past year. Its market capitalisation is ₹10 crore and it trades at 4.2 times earnings.

Share price
₹3.90 (20 Nov 2026)
Market cap
₹10 Cr (20 Nov 2026)
P/E
4.18 (20 Nov 2026)
Revenue
₹24 Cr (June 2026 quarter)
Net profit
₹0 Cr (June 2026 quarter)
ROCE
7.64% (FY26)
ROE
5.22% (FY26)
Book value
₹23.7 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹18.90 / ₹3.62 (20 Nov 2026)
1-year return
-74.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: DPL

Incorporated in 2011, Dipna Pharmachem Ltd is in the business of Pharmaceutical Trading

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.